Piper Jaffray reiterated a Neutral rating on Evogene Ltd (NYSE: EVGN), and cut the price target to $8.00 (from $12.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Evogene Officially Opens Research and Development Facility in St. Louis, MissouriNovember 19, 2015 7:01 AM Evogene Officially Opens Research and Development Facility in St. Louis, MissouriNovember 19, 2015 7:00 AM Evogene Ltd. (EVGN) Tops Q3 EPS by 2cNovember 18, 2015 7:11 AM Evogene Reports Third Quarter 2015 Financial ResultsNovember 18, 2015 7:10 AM Trading Radar for 11/18: Target (TGT), salesforce (CRM), Staples (SPLS), Lowe's (LOW), Hillenbrand (HI) ReportNovember 17, 2015 3:54 PM